Zhou Yanming, Liu Shuncui, Wu Lupeng, Wan Tao
Department of Hepatobiliary and Pancreatovascular Surgery, First Affiliated Hospital of Xiamen University, Xiamen, China.
Department of Hepatobiliary and Pancreatovascular Surgery, First Affiliated Hospital of Xiamen University, Xiamen, China.
Asian J Surg. 2017 Apr;40(2):129-138. doi: 10.1016/j.asjsur.2015.07.002. Epub 2015 Aug 31.
BACKGROUND/OBJECTIVE: This study aimed to assess the available evidence on the survival of distal cholangiocarcinoma (DCC) patients following resection with curative intent and analyze the prognostic factors.
Relevant studies published between January 2000 and January 2015 were identified by searching PubMed and Embase and reviewed systematically. Summary relative risks (RR) and 95% confidence intervals (95% CI) were estimated using random-effects models.
A total of 39 observational studies involving 3258 patients were included in the review. R0 resection was achieved in 84% (range, 46-100%) of patients. The median 5-year overall survival rate after resection was 37% (range, 13-54%), with corresponding rate of 44% (range, 27-63%) in R0 resection. The meta-analysis for 25 studies showed that R1 resection (RR 2.36, 95% CI 1.89-2.93), lymph node metastasis (RR 2.35, 95% CI 1.89-2.93), perineural invasion (RR 1.96, 95% CI 1.64-2.34), lymphatic invasion (RR 1.84, 95% CI 1.47-2.31), vascular invasion (RR 1.99, 95% CI 1.40-2.82), pancreatic invasion (RR 2.13, 95% CI 1.39-3.27), and pathological tumor stage ≥ T3 (RR 1.56, 95% CI 1.25-1.93) were associated with shorter survival.
In general, prognosis of DCC after resection is poor. R0 resection results in a substantially improved survival and represents one of the most important prognostic variables.
背景/目的:本研究旨在评估远端胆管癌(DCC)患者行根治性切除术后生存情况的现有证据,并分析预后因素。
通过检索PubMed和Embase数据库,确定2000年1月至2015年1月间发表的相关研究,并进行系统综述。采用随机效应模型估计汇总相对风险(RR)和95%置信区间(95%CI)。
本综述共纳入39项观察性研究,涉及3258例患者。84%(范围46%-100%)的患者实现了R0切除。切除术后的中位5年总生存率为37%(范围13%-54%),R0切除患者的相应生存率为44%(范围27%-63%)。对25项研究的荟萃分析表明,R1切除(RR 2.36,95%CI 1.89-2.93)、淋巴结转移(RR 2.35,95%CI 1.89-2.93)、神经周围侵犯(RR 1.96,95%CI 1.64-2.34)、淋巴管侵犯(RR 1.84,95%CI 1.47-2.31)、血管侵犯(RR 1.99,95%CI 1.40-2.82)、胰腺侵犯(RR 2.13,95%CI 1.39-3.27)以及病理肿瘤分期≥T3(RR 1.56,95%CI 1.25-1.93)与生存期缩短相关。
总体而言,DCC切除术后预后较差。R0切除可显著提高生存率,是最重要的预后变量之一。